FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions

Korábbi kezelés

• Currently participating in an investigational (drug, device, etc.) clinical trial that will influence the endovascular procedure or acute treatment. Participants in secondary prevention, observational, natural history and/or epidemiological studies are eligible.

Más betegség

• Current hospitalization at time of stroke onset and/or any comorbid disease or condition expected to compromise survival or ability to complete follow-up assessments through 90 days
• Other medical, behavioral, or psychological conditions that in the opinion of the Investigator could limit the ability to participate in the study, including compliance with follow-up requirements, or that could impact the scientific integrity of the study

Egyéb

• Any stenosis or occlusion in the ICA origin requiring treatment during the procedure or within the 90-day follow-up period.
• Known multiple occlusions
• Secondary M2 occlusion
• Known or high suspicion of underlying ICAD as the cause of the M2 occlusion

• Participant age ≥ 18
• Participant experiencing acute ischemic stroke due to a confirmed primary M2 occlusion in the vertical segment or post-bifurcation in the non-dominant or co-dominant branch of the horizontal segment
• NIHSS ≥5 or NIHSS 3-4 with disabling symptoms
• Pre-stroke mRS 0-1
• For participants undergoing thrombectomy: Planned first-line treatment with Penumbra System reperfusion catheters
• Informed consent obtained per Institutional Review Board/Ethics Committee requirements